Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Maria Dalamaga, Stergios A. Polyzos, Konstantinos Karmaniolas, John Chamberland, Antigoni Lekka, Maria Triantafilli, Ilias Migdalis, Evangelia Papadavid & Christos S. Mantzoros. (2016) Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study. Leukemia & Lymphoma 57:3, pages 577-584.
Read now
Read now
Andreas Agathangelidis, Anna Vardi, Panagiotis Baliakas & Kostas Stamatopoulos. (2014) Stereotyped B-cell receptors in chronic lymphocytic leukemia. Leukemia & Lymphoma 55:10, pages 2252-2261.
Read now
Read now
Stefano Molica. (2014) Is it perhaps time for a comprehensive international prognostic index in chronic lymphocytic leukemia?. Leukemia & Lymphoma 55:4, pages 964-965.
Read now
Read now
Silvia Martinelli, Meena Kanduri, Rossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, Roberto Marasca & Richard Rosenquist. (2013) promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia. Epigenetics 8:7, pages 720-729.
Read now
Read now
Articles from other publishers (44)
Karen J. Ortiz‐Ortiz, Carlos R. Torres‐Cintrón, Tonatiuh Suárez Ramos, Maira A. Castañeda‐Avila, Luis A. Cotto Santana & Guillermo Tortolero‐Luna. (2022) Patterns of use of biological and genetic markers for chronic lymphocytic leukemia and acute myeloid leukemia in Puerto Rico. Cancer Medicine 12:6, pages 6889-6901.
Crossref
Crossref
Zekhethelo A. Mkhwanazi, Tawanda M. Nyambuya, Snenhlanhla A. Mfusi & Bongani B. Nkambule. (2022) Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors. BMC Cancer 22:1.
Crossref
Crossref
Daniela Cilloni, Federico Itri, Valentina Bonuomo & Jessica Petiti. (2022) SF3B1 Mutations in Hematological Malignancies. Cancers 14:19, pages 4927.
Crossref
Crossref
Abibatou Sall, Moussa Seck, Seynabou Fall, Fatimata Bintou Sall, Blaise Félix Faye, Fatou Samba Ndiaye, Macoura Gadji, Saliou Diop, Awa Oumar Touré & Martine Raphaël. (2022) Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy 44:1, pages 63-69.
Crossref
Crossref
Salem H. Alshemmari, Abdulaziz Hamdah, Ramesh Pandita & Anita Kunhikrishnan. (2021) Chronic lymphocytic leukemia in a young population. Leukemia Research 110, pages 106668.
Crossref
Crossref
Dhanlaxmi Shetty, Hemani Jain, Yogita Rohil, Navin Khattry, Manju Sengar, Bhausaheb Bagal, Hasmukh Jain, Anant Gokarn, Sachin Punatar, VenkataNaga Avinash Bonda & PG Subramanian. (2021) Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia. Indian Journal of Medical Research 153:4, pages 475.
Crossref
Crossref
Yu. V. Shatokhin, I. V. Snezhko, A. N. Zeltser, S. V. Mordanov, E. V. Burnasheva, L. P. Sizyakina, M. V. Kharitonova, E. V. Ryabikina, O. V. Gerasimova, G. Yu. Nagornaya, A. A. Matsuga & L. I. Dyatchina. (2020) Possibilities of effective antitumor therapy of patients with chronic lymphocytic leukemia depending on the clinical and laboratory characteristics of the disease. South Russian Journal of Therapeutic Practice 1:3, pages 84-90.
Crossref
Crossref
Vojin Vukovic, Teodora Karan-Djurasevic, Darko Antic, Natasa Tosic, Tatjana Kostic, Irena Marjanovic, Marija Dencic-Fekete, Vladislava Djurasinovic, Sonja Pavlovic & Biljana Mihaljevic. (2019) Association of SLC28A3 Gene Expression and CYP2B6*6 Allele with the Response to Fludarabine Plus Cyclophosphamide in Chronic Lymphocytic Leukemia Patients. Pathology & Oncology Research 26:2, pages 743-752.
Crossref
Crossref
Essohana Padaro, Yao Layibo, Irénée Délagnon Messanh Kueviakoe, Kossi Agbétiafa, Hèzouwè Magnang, Nicole Delali Akossiwa Koudokpo, Koffi Mawussi & Ahoefa Vovor. (2019) Caractéristiques de la leucémie lymphoïde chronique au Togo. Pan African Medical Journal 34.
Crossref
Crossref
Salah Aref, Nadia El Menshawy, Mohamed Sabry El-Ghonemy, Ghada El-Said & Mohamed Ali El-Baiomy. (2018) Prognostic relevance of CD69 expression in B cell chronic lymphocytic leukemia. Comparative Clinical Pathology 28:1, pages 33-40.
Crossref
Crossref
Farzaneh Bozorg-Ghalati, Iraj Mohammadpour & Reza Ranjbaran. (2017) Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine. Comparative Clinical Pathology 28:1, pages 3-10.
Crossref
Crossref
Amal Abd El Hamid Mohamed & Nesma Ahmed Safwat. (2018) New insights into smudge cell percentage in chronic lymphocytic Leukemia: A novel prognostic indicator of disease burden. Egyptian Journal of Medical Human Genetics 19:4, pages 409-415.
Crossref
Crossref
Maurizio Cavallari, Francesco Cavazzini, Antonella Bardi, Eleonora Volta, Aurora Melandri, Elisa Tammiso, Elena Saccenti, Enrico Lista, Francesca Maria Quaglia, Antonio Urso, Michele Laudisi, Elisa Menotti, Luca Formigaro, Melissa Dabusti, Maria Ciccone, Paolo Tomasi, Massimo Negrini, Antonio Cuneo & Gian Matteo Rigolin. (2018) Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia. Oncotarget 9:76, pages 34398-34412.
Crossref
Crossref
Iben Daugaard, Dianna Hussmann, Louise Kristensen, Thomas Kristensen, Tina E Kjeldsen, Charlotte G Nyvold, Thomas S Larsen, Michael B Møller, Lise Lotte Hansen & Tomasz K Wojdacz. (2018)
Chronic lymphocytic leukemia patients with heterogeneously or fully methylated
LPL
promotor display longer time to treatment
. Epigenomics 10:9, pages 1155-1166.
Crossref
Crossref
Daniel Prieto, Noé Seija, Angimar Uriepero, Thais Souto-Padron, Carolina Oliver, Victoria Irigoin, Cecilia Guillermo, Marcelo A. Navarrete, Ana Inés Landoni, Guillermo Dighiero, Raúl Gabus, Mirta Giordano & Pablo Oppezzo. (2018) LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL. British Journal of Haematology 182:4, pages 521-525.
Crossref
Crossref
Larry Mansouri, Justyna Anna Wierzbinska, Christoph Plass & Richard Rosenquist. (2018) Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact. Seminars in Cancer Biology 51, pages 1-11.
Crossref
Crossref
Jasmine Chauzeix, Marie‐Pierre Laforêt, Mélanie Deveza, Liam Crowther, Elodie Marcellaud, Paco Derouault, Anne‐Sophie Lia, François Boyer, Nicolas Bargues, Guillaume Olombel, Arnaud Jaccard, Jean Feuillard, Nathalie Gachard & David Rizzo. (2018)
Normal serum protein electrophoresis and mutated
IGHV
genes detect very slowly evolving chronic lymphocytic leukemia patients
. Cancer Medicine 7:6, pages 2621-2628.
Crossref
Crossref
Juliana Carvalho Alves-Silva, Doralina do Amaral Rabello, Martha Oliveira Bravo, Antônio Lucena-Araujo, Diego Madureira de Oliveira, Fábio Morato de Oliveira, Eduardo Magalhaes Rego, Fábio Pittella-Silva & Felipe Saldanha-Araujo. (2017)
Aberrant levels of
SUV39H1
and
SUV39H2
methyltransferase are associated with genomic instability in chronic lymphocytic leukemia
. Environmental and Molecular Mutagenesis 58:9, pages 654-661.
Crossref
Crossref
Jennifer Goy, Tanya L. Gillan, Helene Bruyere, Steven J.T. Huang, Monica Hrynchak, Aly Karsan, Khaled Ramadan, Joseph Connors, Cynthia L. Toze & Alina S. Gerrie. (2017) Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada. Clinical Lymphoma Myeloma and Leukemia 17:6, pages 382-389.
Crossref
Crossref
R. Stauder, B. Eichhorst, M.E. Hamaker, K. Kaplanov, V.A. Morrison, A. Österborg, I. Poddubnaya, J.A. Woyach, T. Shanafelt, L. Smolej, L. Ysebaert & V. Goede. (2017) Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force. Annals of Oncology 28:2, pages 218-227.
Crossref
Crossref
K Stamatopoulos, A Agathangelidis, R Rosenquist & P Ghia. (2016) Antigen receptor stereotypy in chronic lymphocytic leukemia. Leukemia 31:2, pages 282-291.
Crossref
Crossref
Francesca Arruga & Silvia Deaglio. 2018. Mechanisms of Drug Resistance in Cancer Therapy. Mechanisms of Drug Resistance in Cancer Therapy
203
229
.
A. P. Kozlov. (2016) Expression of evolutionarily novel genes in tumors. Infectious Agents and Cancer 11:1.
Crossref
Crossref
Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye, Claire Mathiot, Sophie Reynaud, Saliou Diop & Martine Raphaël. (2016) Characteristics of chronic lymphocytic leukemia in Senegal. BMC Hematology 16:1.
Crossref
Crossref
Eric Duncavage, Ranjana H. Advani, Steven Agosti, Philip Foulis, Christine Gibson, Loveleen Kang, Joseph D. Khoury, L. Jeffrey Medeiros, Robert S. Ohgami, Dennis P. O'Malley, Keyur P. Patel, Jason N. Rosenbaum & Carla Wilson. (2016) Template for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Archives of Pathology & Laboratory Medicine 140:11, pages 1228-1230.
Crossref
Crossref
Louise Kristensen, Thomas Kristensen, Niels Abildgaard, Cristina Royo, Mikael Frederiksen, Torben Mourits-Andersen, Elias Campo & Michael Boe M?ller. (2016)
LPL
gene expression is associated with poor prognosis in CLL and closely related to
NOTCH1
mutations
. European Journal of Haematology 97:2, pages 175-182.
Crossref
Crossref
Wilson Oliveira-Santos, Doralina Amaral Rabello, Antônio Roberto Lucena-Araujo, Fábio Morato de Oliveira, Eduardo Magalhaes Rego, Fábio Pittella Silva & Felipe Saldanha-Araujo. (2016) Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology 37:7, pages 9473-9481.
Crossref
Crossref
P. Baliakas, M. Mattsson, K. Stamatopoulos & R. Rosenquist. (2016) Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?. Journal of Internal Medicine 279:4, pages 347-357.
Crossref
Crossref
Gera D. te Raa & Arnon P. Kater. (2016) TP53 dysfunction in CLL: Implications for prognosis and treatment. Best Practice & Research Clinical Haematology 29:1, pages 90-99.
Crossref
Crossref
Antoine Abi Lutfallah, Hampig Raphael Kourie, Roland Eid, Fadi Farhat, Marwan Ghosn & Joseph Kattan. (2016) Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?. Asian Pacific Journal of Cancer Prevention 17:1, pages 215-217.
Crossref
Crossref
David Allard, Bertrand Allard, Pierre-Olivier Gaudreau, Pavel Chrobak & John Stagg. (2016) CD73–adenosine: a next-generation target in immuno-oncology. Immunotherapy 8:2, pages 145-163.
Crossref
Crossref
Itziar Salaverria, David Martín‐Garcia, Cristina López, Guillem Clot, Manel García‐Aragonés, Alba Navarro, Julio Delgado, Tycho Baumann, Magda Pinyol, Idoia Martin‐Guerrero, Ana Carrió, Dolors Costa, Ana C. Queirós, Sandrine Jayne, Marta Aymerich, Neus Villamor, Dolors Colomer, Marcos González, Armando López‐Guillermo, Elías Campo, Martin J. S. Dyer, Reiner Siebert, Lluís Armengol & Sílvia Beà. (2015) Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia. Genes, Chromosomes and Cancer 54:11, pages 668-680.
Crossref
Crossref
Andrea Visentin, Monica Facco, Federica Frezzato, Monica Castelli, Valentina Trimarco, Veronica Martini, Cristina Gattazzo, Filippo Severin, Giorgia Chiodin, Annalisa Martines, Laura Bonaldi, Ilaria Gianesello, Elisa Pagnin, Elisa Boscaro, Francesco Piazza, Renato Zambello, Gianpietro Semenzato & Livio Trentin. (2015) Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 15:10, pages 612-620.e5.
Crossref
Crossref
Thomas Menter, Stephan Dirnhofer & Alexandar Tzankov. (2015) LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma. Journal of Clinical Pathology 68:6, pages 473-478.
Crossref
Crossref
Mohammad Shahjahani, Javad Mohammadiasl, Fatemeh Noroozi, Mohammad Seghatoleslami, Saeid Shahrabi, Fakhredin Saba & Najmaldin Saki. (2015) Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. Cellular Oncology 38:2, pages 93-109.
Crossref
Crossref
D Rizzo, J Chauzeix, F Trimoreau, J B Woillard, F Genevieve, A Bouvier, J Labrousse, C Poli, E Guerin, N Dmytruk, L Remenieras, J Feuillard & N Gachard. (2014) IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events. Leukemia 29:2, pages 337-345.
Crossref
Crossref
Linping Hu, Kun Ru, Li Zhang, Yuting Huang, Xiaofan Zhu, Hanzhi Liu, Anders Zetterberg, Tao Cheng & Weimin Miao. (2014) Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomarker Research 2:1.
Crossref
Crossref
S E M Herman, C U Niemann, M Farooqui, J Jones, R Z Mustafa, A Lipsky, N Saba, S Martyr, S Soto, J Valdez, J A Gyamfi, I Maric, K R Calvo, L B Pedersen, C H Geisler, D Liu, G E Marti, G Aue & A Wiestner. (2014) Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia 28:11, pages 2188-2196.
Crossref
Crossref
Prerna Mewawalla & Sunita Nathan. (2014) Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review. Therapeutic Advances in Hematology 5:5, pages 139-152.
Crossref
Crossref
D Cortese, L-A Sutton, N Cahill, K E Smedby, C Geisler, R Gunnarsson, G Juliusson, L Mansouri & R Rosenquist. (2013) On the way towards a ‘CLL prognostic index’: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia 28:3, pages 710-713.
Crossref
Crossref
Panagiotis Baliakas, Michalis Iskas, Anne Gardiner, Zadie Davis, Karla Plevova, Florence Nguyen-Khac, Jitka Malcikova, Achilles Anagnostopoulos, Sharron Glide, Sarah Mould, Kristina Stepanovska, Martin Brejcha, Chrysoula Belessi, Frederic Davi, Sarka Pospisilova, Anastasia Athanasiadou, Kostas Stamatopoulos & David Oscier. (2014) Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data. American Journal of Hematology 89:3, pages 249-255.
Crossref
Crossref
Elias Bou Samra, Bernard Klein, Thérèse Commes & Jérôme Moreaux. (2014) Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Larry Mansouri, Pawel Grabowski, Sofie Degerman, Ulrika Svenson, Rebeqa Gunnarsson, Nicola Cahill, Karin Ekström Smedby, Christian Geisler, Gunnar Juliusson, Göran Roos & Richard Rosenquist. (2013)
Short telomere length is associated with
NOTCH1/SF3B1/TP53
aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
. American Journal of Hematology 88:8, pages 647-651.
Crossref
Crossref
Kathy Heel, Tania Tabone, Kimberley J. Röhrig, Phillip G. Maslen, Katie Meehan, Lizz F. Grimwade & Wendy N. Erber. (2013) Developments in the immunophenotypic analysis of haematological malignancies. Blood Reviews 27:4, pages 193-207.
Crossref
Crossref